Akari Therapeutics Plc Quarterly Income Tax Expense (Benefit) in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Akari Therapeutics Plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2014 to Q2 2024.
  • Akari Therapeutics Plc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $0.000.
  • Akari Therapeutics Plc annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Akari Therapeutics Plc annual Income Tax Expense (Benefit) for 2022 was -$74K.
  • Akari Therapeutics Plc annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $0 $0 Apr 1, 2024 Jun 30, 2024 8-K 2024-09-06
Q2 2023 $0 Apr 1, 2023 Jun 30, 2023 8-K 2024-09-06
Q1 2016 $0 $0 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $0 $0 $0 Oct 1, 2015 Dec 31, 2015 20-F 2018-07-18
Q3 2015 $0 $0 $0 Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-23
Q2 2015 $0 $0 $0 Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-12
Q1 2015 $0 $0 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 $0 $0 Oct 1, 2014 Dec 31, 2014 20-F 2017-03-31
Q3 2014 $0 Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-23
Q2 2014 $0 Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 $0 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.